DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
34. 神経線維腫症
Neurofibromatosis
Clinical trials
/
Disease details
臨床試験数
:
133
/
薬物数
:
186
- (
DrugBank
:
67
) /
標的遺伝子数
:
79
-
標的パスウェイ数
:
190
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2016-005022-10-DE
(
EUCTR
)
13/02/2018
09/11/2017
Improvement of synaptic plasticity and cognitive function in RAS pathway disorders
Improvement of synaptic plasticity and cognitive function in RAS pathway disorders
Noonan Syndrom and Neurofibromatosis Type 1
MedDRA version: 20.0;Level: PT;Classification code 10029748;Term: Noonan syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders
MedDRA version: 20.0;Classification code 10029268;Term: Neurofibromatosis;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Not possible to specify
Noonan Syndrom and Neurofibromatosis Type 1
MedDRA version: 20.0;Level: PT;Classification code 10029 ...
Product Name:
Lovastatin
INN or Proposed INN:
Lovastatin
Other descriptive name:
LOVASTATIN
Product Name:
Lamotrigin
beta
INN or Proposed INN:
Lamotrigin
Product Name:
Lovastatin
INN or Proposed INN:
Lovastatin
Other descriptive name:
LOVASTATIN
Product Nam ...
Technische Universität München, Fakultät für Medizin
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
30
Phase 2
Germany